Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake.

    Vänttinen M, Nuutila P, Kuulasmaa T, Pihlajamäki J, Hällsten K, Virtanen KA, Lautamäki R, Peltoniemi P, Takala T, Viljanen AP, Knuuti J, Laakso M.

    Diabetes. 2005 Dec;54(12):3587-91.PMID: 16306381 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study.

    Vänttinen M, Nuutila P, Pihlajamäki J, Hällsten K, Virtanen KA, Lautamäki R, Peltoniemi P, Kemppainen J, Takala T, Viljanen AP, Knuuti J, Laakso M.

    J Clin Endocrinol Metab. 2005 Jul;90(7):4249-54. Epub 2005 Apr 26.PMID: 15855261 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.

    Stefan N, Thamer C, Staiger H, Machicao F, Machann J, Schick F, Venter C, Niess A, Laakso M, Fritsche A, Häring HU.

    J Clin Endocrinol Metab. 2007 May;92(5):1827-33. Epub 2007 Feb 27.PMID: 17327385 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.

    Staiger H, Haas C, Machann J, Werner R, Weisser M, Schick F, Machicao F, Stefan N, Fritsche A, Häring HU.

    Diabetes. 2009 Mar;58(3):579-89. Epub 2008 Dec 15.PMID: 19074989 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Variation in the peroxisome proliferator-activated receptor delta gene in relation to common metabolic traits in 7,495 middle-aged white people.

    Grarup N, Albrechtsen A, Ek J, Borch-Johnsen K, Jørgensen T, Schmitz O, Hansen T, Pedersen O.

    Diabetologia. 2007 Jun;50(6):1201-8. Epub 2007 Apr 13.PMID: 17431579 [PubMed - indexed for MEDLINE]Related articles

    7.

    Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study.

    Thamer C, Machann J, Stefan N, Schäfer SA, Machicao F, Staiger H, Laakso M, Böttcher M, Claussen C, Schick F, Fritsche A, Haring HU.

    J Clin Endocrinol Metab. 2008 Apr;93(4):1497-500. Epub 2008 Feb 5.PMID: 18252792 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Early postnatal oestradiol exposure causes insulin resistance and signs of inflammation in circulation and skeletal muscle.

    Alexanderson C, Eriksson E, Stener-Victorin E, Lönn M, Holmäng A.

    J Endocrinol. 2009 Apr;201(1):49-58. Epub 2009 Feb 4.PMID: 19193715 [PubMed - indexed for MEDLINE]Related articles

    10.

    Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.

    Kannisto K, Chibalin A, Glinghammar B, Zierath JR, Hamsten A, Ehrenborg E.

    Int J Mol Med. 2006 Jan;17(1):45-52.PMID: 16328010 [PubMed - indexed for MEDLINE]Related articles

    11.

    Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation.

    Fredenrich A, Grimaldi PA.

    Curr Opin Clin Nutr Metab Care. 2004 Jul;7(4):377-81. Review.PMID: 15192438 [PubMed - indexed for MEDLINE]Related articles

    12.

    Activation of PPAR-delta in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids.

    Brunmair B, Staniek K, Dörig J, Szöcs Z, Stadlbauer K, Marian V, Gras F, Anderwald C, Nohl H, Waldhäusl W, Fürnsinn C.

    Diabetologia. 2006 Nov;49(11):2713-22. Epub 2006 Sep 8.PMID: 16960684 [PubMed - indexed for MEDLINE]Related articles

    13.

    Peroxisome proliferator-activated receptor-delta, a regulator of oxidative capacity, fuel switching and cholesterol transport.

    Fürnsinn C, Willson TM, Brunmair B.

    Diabetologia. 2007 Jan;50(1):8-17. Epub 2006 Nov 22. Review.PMID: 17119917 [PubMed - indexed for MEDLINE]Related articles

    14.

    Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy.

    Hadigan C, Kamin D, Liebau J, Mazza S, Barrow S, Torriani M, Rubin R, Weise S, Fischman A, Grinspoon S.

    Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E289-98. Epub 2005 Aug 30.PMID: 16131513 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy.

    Behrens GM, Boerner AR, Weber K, van den Hoff J, Ockenga J, Brabant G, Schmidt RE.

    J Clin Invest. 2002 Nov;110(9):1319-27.PMID: 12417571 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A single nucleotide polymorphism on exon-4 of the gene encoding PPARdelta is associated with reduced height in adults and children.

    Burch LR, Zhou K, Donnelly LA, Doney AS, Brady J, Goddard C, Morris AD, Hansen MK, Palmer CN.

    J Clin Endocrinol Metab. 2009 Jul;94(7):2587-93. Epub 2009 Apr 21.PMID: 19383774 [PubMed - indexed for MEDLINE]Related articles

    18.

    Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.

    Krämer DK, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves PM, Krook A.

    J Biol Chem. 2007 Jul 6;282(27):19313-20. Epub 2007 May 11.PMID: 17500064 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake.

    Hu X, Feng Y, Liu X, Zhao XF, Yu JH, Yang YS, Sydow-Bäckman M, Hörling J, Zierath JR, Leng Y.

    Diabetologia. 2007 May;50(5):1048-57. Epub 2007 Mar 1.PMID: 17333104 [PubMed - indexed for MEDLINE]Related articles

    20.

    Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation.

    Yao-Borengasser A, Rasouli N, Varma V, Miles LM, Phanavanh B, Starks TN, Phan J, Spencer HJ 3rd, McGehee RE Jr, Reue K, Kern PA.

    Diabetes. 2006 Oct;55(10):2811-8.PMID: 17003347 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data